From: Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets
Symbol | Gene name | Cell line (liposarcoma histotype) |
---|---|---|
EGFR | Epidermal growth factor receptor | SW872 (undifferentiated) |
PTK2 | Protein tyrosine kinase 2 (or focal adhesion kinase) | LPS141 (dedifferentiated) |
T778 (well-differentiated) | ||
TXK | Tyrosine-protein kinase | LPS141 (dedifferentiated) |
SYK | Spleen tyrosine kinase | LP6 (dedifferentiated) |
FER | FER (Fps/Fes related) tyrosine kinase | SA4 (dedifferentiated) |
KDR | Kinase insert domain receptor | SA4 (dedifferentiated) |
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | T449 (well-differentiated) |
MLS402 (myxoid) | ||
GOT3 (well-differentiated) | ||
PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | T449 (well-differentiated) |
LiSa-2 (pleomorphic) | ||
STYK1 | Serine/threonine/tyrosine kinase 1 | T778 (well-differentiated) |
EPHA6 | Ephrin type-A receptor 6 | T778 (well-differentiated) |
ROR1 | Receptor tyrosine kinase-like orphan receptor 1 | MLS402 (myxoid) |
JAK1 | Janus kinase 1 | FU-DDLS-1 (dedifferentiated) |
MATK | Megakaryocyte-associated tyrosine kinase | FU-DDLS-1 (dedifferentiated) |
LiSa-2 (pleomorphic) | ||
ROS1 | ROS proto-oncogene 1, receptor tyrosine kinase | FU-DDLS-1 (dedifferentiated) |
MST1R | Macrophage stimulating 1 receptor | LiSa-2 (pleomorphic) |
FLT3 | Fms-related tyrosine kinase 3 | T1000 (well-differentiated) |
JAK2 | Janus kinase 2 | T1000 (well-differentiated) |